Symbol
AEON on NYSE
Investment type
Equity - Shares of Stock
Class
Class A Common Stock
Latest Disclosed Ownership
8.96M shares
Security Ownership
9.99%

L1 Capital Global Opportunities Master Fund, Ltd. ownership in AEON Biopharma, Inc. Class A Common Stock (AEON)

2025-01-13 - L1 Capital Global Opportunities Master Fund, Ltd. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.96M shares of AEON Biopharma, Inc. Class A Common Stock (AEON). This represents 9.99% percent ownership of the company.